Bilateral choroidal metastases from lung cancer symmetrically are rarely seen, and icotinib following by almonertinib was an alternative therapy for choroidal metastasis from NSCLC with EGFR mutation. This evidence concerns the gene EGFR and non-small cell lung carcinoma.